Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Semjonow

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Der Urologe. Ausg. A|September 12, 2007
[DiaPat test for prostate cancer diagnosis]A Semjonow
Der Urologe. Ausg. A|July 1, 1995
[Can the tumor stage of prostate carcinoma be determined with the aid of prostate-specific antigen?]A Semjonow, L Hertle
Der Urologe. Ausg. A|August 25, 2000
[10 years PSA--chemoprevention]P Hammerer, A Semjonow
Psychopharmacology|January 1, 1985
Generalization of the discriminative stimulus properties of delta 9-THC to delta 9(11)-THC in ratsA Semjonow, M Binder
British Journal of Urology|February 1, 1995
Reducing trauma whilst removing long-term indwelling balloon cathetersA Semjonow, S Roth, L Hertle
World Journal of Urology|January 1, 1993
Prediction of tumor recurrence after radical prostatectomy using elimination kinetics of prostate-specific antigenA Semjonow, M Hamm, P Rathert
European Urology|January 1, 1992
Half-life of prostate-specific antigen after radical prostatectomy: the decisive predictor of curative treatment?A Semjonow, M Hamm, P Rathert
Der Urologe. Ausg. A|May 1, 1993
[The quotient of prostate-specific antigen and prostate volume. Improved differentiation between benign prostatic hyperplasia and locally circumscribed prostate cancer]A Semjonow, M Hamm, P Rathert
The International Journal of Biological Markers|January 1, 1994
Elimination kinetics of prostate-specific antigen serum and urineA Semjonow, M Hamm, P Rathert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Prostate-specific antigen doubling time: a potential surrogate end point in hormone-refractory prostate cancerH P Schmid, A Semjonow, R Maibach
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Der Urologe. Ausg. A|September 12, 2007
[DiaPat test for prostate cancer diagnosis]A Semjonow
Der Urologe. Ausg. A|July 1, 1995
[Can the tumor stage of prostate carcinoma be determined with the aid of prostate-specific antigen?]A Semjonow, L Hertle
Der Urologe. Ausg. A|August 25, 2000
[10 years PSA--chemoprevention]P Hammerer, A Semjonow
Psychopharmacology|January 1, 1985
Generalization of the discriminative stimulus properties of delta 9-THC to delta 9(11)-THC in ratsA Semjonow, M Binder
British Journal of Urology|February 1, 1995
Reducing trauma whilst removing long-term indwelling balloon cathetersA Semjonow, S Roth, L Hertle
World Journal of Urology|January 1, 1993
Prediction of tumor recurrence after radical prostatectomy using elimination kinetics of prostate-specific antigenA Semjonow, M Hamm, P Rathert
European Urology|January 1, 1992
Half-life of prostate-specific antigen after radical prostatectomy: the decisive predictor of curative treatment?A Semjonow, M Hamm, P Rathert
Der Urologe. Ausg. A|May 1, 1993
[The quotient of prostate-specific antigen and prostate volume. Improved differentiation between benign prostatic hyperplasia and locally circumscribed prostate cancer]A Semjonow, M Hamm, P Rathert
The International Journal of Biological Markers|January 1, 1994
Elimination kinetics of prostate-specific antigen serum and urineA Semjonow, M Hamm, P Rathert
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1999
Prostate-specific antigen doubling time: a potential surrogate end point in hormone-refractory prostate cancerH P Schmid, A Semjonow, R Maibach
Pageof 6